PERSONALIZED MOLECULARLY GUIDED MANAGEMENT OF ATOPIC DERMATITIS: PROGNOSTIC STRATIFICATION AND CLINICAL OUTCOMES IN A 300-PATIENT COHORT. ICIS 2026, 3 (9), 45-47.